Protocol Ledger

NCT03057054 · Phase III · ACTIVE NOT RECRUITING

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

Interventional Phase III clinical trial protocol NCT03057054 sponsored by Children's Oncology Group in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-04-30 Enrollment: 173 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03057054
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)173 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03057054
Protocol FieldVerified Registry Value
NCT IdentifierNCT03057054
Consolidated Lead SponsorChildren's Oncology Group
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment173 participants (ACTUAL)
Registered Start Date2018-04-30
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI